Abstract
No public abstract is available from the verified source records.
Long-Sheng Fan, Wen-Hui Zhao, Fei-Fei Qu, Xiao-Wen Zeng
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Kinetics of 15 per- and polyfluoroalkyl substances (PFAS) after single oral application as a mixture – A pilot investigation in a male volunteer
10.1016/j.envint.2024.109047 · 2024
Comparative in vitro study of structure related uptake of ten perfluoroalkyl substances by human and rat renal transporters
10.1007/s00204-026-04508-7 · 2026
Evaluation of Maternal, Embryo, and Placental Effects in CD-1 Mice following Gestational Exposure to Perfluorooctanoic Acid (PFOA) or Hexafluoropropylene Oxide Dimer Acid (HFPO-DA or GenX)
10.1289/ehp6233 · 2020
Evaluation of chronic toxicity and carcinogenicity of ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate in Sprague-Dawley rats
10.1016/j.toxrep.2015.06.001 · 2015
Sex, age, and species differences of perfluorooctanoic acid modeled by flow- versus permeability-limited physiologically-based pharmacokinetic models
10.1016/j.tox.2024.153806 · 2024
Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: Development and performance verification
10.1016/j.envint.2019.03.058 · 2019
Development of a Gestational and Lactational Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctane Sulfonate (PFOS) in Rats and Humans and Its Implications in the Derivation of Health-Based Toxicity Values
10.1289/ehp7671 · 2021
10.1016/j.envint.2020.105581
10.1016/j.envint.2020.105581 · 2020
Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat
10.1016/j.envint.2020.106204 · 2021
Latent, sex-specific metabolic health effects in CD-1 mouse offspring exposed to PFOA or HFPO-DA (GenX) during gestation
10.1016/j.emcon.2021.10.004 · 2021
Development of a physiologically based pharmacokinetic model for ethylene glycol and its metabolite, glycolic Acid, in rats and humans
10.1093/toxsci/kfi119 · 2005
Comprehensive Assessment of Exposure Pathways for Perfluoroalkyl Ether Carboxylic Acids (PFECAs) in Residents Near a Fluorochemical Industrial Park: The Unanticipated Role of Cereal Consumption
10.1021/acs.est.3c06910 · 2023
Nationwide distribution of perfluoroalkyl ether carboxylic acids in Chinese diets: An emerging concern
10.1016/j.envint.2024.108648 · 2024
Toxicokinetics of perfluorohexanoic acid (PFHxA), perfluorooctanoic acid (PFOA) and perfluorodecanoic acid (PFDA) in male and female Hsd:Sprague dawley SD rats following intravenous or gavage administration
10.1080/00498254.2019.1683776 · 2020
Unresolved referenced work
Kept as external metadata until matched
Quantitative Systems Pharmacology and Physiologically‐Based Pharmacokinetic Modeling With mrgsolve: A Hands‐On Tutorial
2019
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
External and internal human exposure to PFOA and HFPOs around a mega fluorochemical industrial park, China: Differences and implications
10.1016/j.envint.2021.106824 · 2021
Sex Differences in Pharmacokinetics and Pharmacodynamics
10.1146/annurev.pharmtox.44.101802.121453 · 2004
Absorption, distribution, metabolism, excretion, and kinetics of 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid ammonium salt following a single dose in rat, mouse, and cynomolgus monkey
10.1016/j.tox.2015.12.006 · 2016
Comparing the toxic potency in vivo of long-chain perfluoroalkyl acids and fluorinated alternatives
10.1016/j.envint.2018.01.011 · 2018
Exposure to GenX and Its Novel Analogs Disrupts Hepatic Bile Acid Metabolism in Male Mice
2021
Emerging Perfluorinated Chemical GenX: Environmental and Biological Fates and Risks
2024
Liver Hypertrophy: A Review of Adaptive (Adverse and Non-adverse) Changes—Conclusions from the 3rd International ESTP Expert Workshop
10.1177/0192623312448935 · 2012
PFOA substitute GenX at a sub-cytotoxic level exhibits thyroid-disrupting effects by inhibiting the expression of thyroid transcription factor 1
10.1016/j.envpol.2024.125594 · 2025
Hematological effects in F344 rats and B6C3F1 mice during the 13-week gavage toxicity study of methylene blue trihydrate
10.1093/toxsci/65.1.126 · 2002
Kynurenic Acid Plays a Protective Role in Hepatotoxicity Induced by HFPO-DA in Male Mice
10.1021/acs.est.3c08033 · 2024
Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89
2002
Harnessing PET to track micro- and nanoplastics in vivo
10.1038/s41598-021-90929-6 · 2021
Exploring sex differences in human health risk assessment for PFNA and PFDA using a PBPK model
10.1007/s00204-018-2365-y · 2019
Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model
10.1007/s00204-017-2116-5 · 2018
Investigating mouse hepatic lipidome dysregulation following exposure to emerging per- and polyfluoroalkyl substances (PFAS)
10.1016/j.chemosphere.2024.141654 · 2024
Measurement of Novel, Drinking Water-Associated PFAS in Blood from Adults and Children in Wilmington, North Carolina
2020
PBPK modeling of C7 HFPO-TA: Linking mouse pharmacokinetics to human exposure and risk through biomonitoring data
10.1016/j.jhazmat.2026.142490 · 2026
Legacy per- and polyfluoroalkyl substances (PFASs) and alternatives (short-chain analogues, F-53B, GenX and FC-98) in residential soils of China: Present implications of replacing legacy PFASs
10.1016/j.envint.2019.105419 · 2020
A physiologically based pharmacokinetic model for atrazine and its main metabolites in the adult male C57BL/6 mouse
10.1016/j.taap.2010.11.009 · 2011
Novel insights into the mechanisms of bioaccumulation and tissue-specific distribution of hexafluoropropylene oxide homologues, novel PFOA alternatives, in zebrafish (Danio rerio)
10.1016/j.envint.2024.109053 · 2024
Estimation of species- and sex-specific PFAS pharmacokinetics in mice, rats, and non-human primates using a Bayesian hierarchical methodology
10.1016/j.taap.2025.117336 · doi-reference
Sex- and Age-Related Metabolic Characteristics of Serum Free Fatty Acids in Healthy Chinese Adults
10.1021/acs.jproteome.9b00502 · doi-reference
Per- and polyfluoroalkyl substances in Chinese surface waters: A review
10.1016/j.ecoenv.2023.115178 · doi-reference
Development of a Physiologically Based Pharmacokinetic (PBPK) Model for F-53B in Pregnant Mice and Its Extrapolation to Humans
10.1021/acs.est.4c05405 · doi-reference
Development and Human Extrapolation of Physiologically Based Toxicokinetic Models for Chlorinated Polyfluoroalkyl Ether Sulfonates from Rats
10.1021/acs.est.5c18780 · doi-reference
Accumulation and glucocorticoid signaling suppression by four emerging perfluoroethercarboxylic acids based on animal exposure and cell testing
10.1016/j.envint.2023.108092 · doi-reference
Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis
10.1289/ehp11814 · doi-reference
Novel Perfluoroalkyl Ether Carboxylic Acids (PFECAs) and Sulfonic Acids (PFESAs): Occurrence and Association with Serum Biochemical Parameters in Residents Living Near a Fluorochemical Plant in China
10.1021/acs.est.0c02888 · doi-reference
Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A
10.1016/j.taap.2015.10.016 · doi-reference
Perfluorooctanoic acid and its alternatives disrupt the osteogenesis and osteoclastogenesis balance: Evidence from the effects on cell differentiation process
10.1016/j.scitotenv.2024.178331 · doi-reference
Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations
10.1016/j.taap.2017.07.001 · doi-reference
Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat
10.1016/j.taap.2015.10.017 · doi-reference
Uptake, distribution, and depuration of emerging per- and polyfluoroalkyl substances in mice: Role of gut microbiota
10.1016/j.scitotenv.2022.158372 · doi-reference
Differential Developmental Neurotoxicity and Tissue Uptake of the Per- and Polyfluoroalkyl Substance Alternatives, GenX and PFBS
10.1021/acs.est.3c05023 · doi-reference
A review of sources, multimedia distribution and health risks of novel fluorinated alternatives
10.1016/j.ecoenv.2019.109402 · doi-reference
GenX caused liver injury and potential hepatocellular carcinoma of mice via drinking water even at environmental concentration
10.1016/j.envpol.2024.123574 · doi-reference
Estrogen-induced changes in protein binding of bupivacaine during in vitro fertilization
10.1097/00000542-199710000-00023 · doi-reference
Integration of mechanistic and repeat dose toxicity data in the derivation of an oral reference dose for HFPO-DA
10.1093/toxsci/kfag045 · doi-reference
Evaluation of chronic toxicity and carcinogenicity of HFPO-DA in mice
10.1016/j.yrtph.2025.106014 · doi-reference
Development of an oral reference dose for the perfluorinated compound GenX
10.1002/jat.3812 · doi-reference
Emissions, Transport, and Fate of Emerging Per- and Polyfluoroalkyl Substances from One of the Major Fluoropolymer Manufacturing Facilities in China
10.1021/acs.est.7b06657 · doi-reference
Inverse Modelling, Sensitivity and Monte Carlo Analysis in R Using Package FME
10.18637/jss.v033.i03 · doi-reference
Comparison of bioconcentration and kinetics of GenX in tilapia Oreochromis mossambicus in fresh and brackish water
10.1016/j.chemosphere.2021.132289 · doi-reference
A Web-Based System for Bayesian Benchmark Dose Estimation
10.1289/ehp1289 · doi-reference
Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury
10.1016/j.envint.2021.106843 · doi-reference
Serum concentrations of legacy and emerging per- and polyfluoroalkyl substances in the Anniston Community Health Surveys (ACHS I and ACHS II)
10.1016/j.envint.2021.106907 · doi-reference
10.1021/envhealth.6c00088
10.1021/envhealth.6c00088 · doi-reference
Mixtures of per- and polyfluoroalkyl substances (PFAS) alter sperm methylation and long-term reprogramming of offspring liver and fat transcriptome
10.1016/j.envint.2024.108577 · doi-reference
Sources, occurrence and toxic effects of emerging per- and polyfluoroalkyl substances (PFAS)
10.1016/j.ntt.2023.107174 · doi-reference
Prenatal Exposure of PFAS in Cohorts of Pregnant Women: Identifying the Critical Windows of Vulnerability and Health Implications
10.1021/acs.est.4c00453 · doi-reference
Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model
10.1016/j.reprotox.2011.04.006 · doi-reference
Risk assessment and source identification of perfluoroalkyl acids in surface and ground water: Spatial distribution around a mega-fluorochemical industrial park, China
10.1016/j.envint.2016.02.020 · doi-reference